Bioorganic & Medicinal Chemistry

Papers
(The H4-Index of Bioorganic & Medicinal Chemistry is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Synthesis and antiproliferative activity of (−)-cleistenolide, (6S)-cleistenolide and 4-substituted cleistenolide analogues113
Synthesis and biological evaluation of pyrazole-fused oleanolic acid derivatives as novel inhibitors of inflammatory and osteoclast differentiation99
Production and synthesis of a novel 191Pt-labeled platinum complex and evaluation of its biodistribution in healthy mice86
A DNA-encoded library special issue82
Discovery of novel 2,8-diazaspiro[4.5]decan-1-one derivatives as potent RIPK1 kinase inhibitors68
Discovery of 5-methylpyrimidopyridone analogues as selective antimycobacterial agents64
Targeting prolidase. A survey of the literature data to depict a structure-activity relationship frame and to address future studies for drug development47
Current Japanese pharmaceutical chemistry45
Site-specific construction of triptolide-based antibody-drug conjugates42
RNA-templated chemical synthesis of proapoptotic L- and d-peptides39
Graphical abstract TOC39
Graphical abstract TOC38
Contents continued38
Editorial Board36
Development of delivery carriers for plasmid DNA by conjugation of a helical template to oligoarginine36
Diterpenoids from the whole plants of Croton yunnanensis and their bioactivities36
Design, synthesis and antibacterial evaluation of oxazolidinone derivatives containing N-methylglycyl or quaternary ammonium salts35
Crescent-shaped meta-substituted benzene derivatives as a new class of non-nucleoside ribonuclease A inhibitors34
Synthesis and medicinal chemistry of tetronamides: Promising agrochemicals and antitumoral compounds33
Discovery of 3-hydroxymethyl-azetidine derivatives as potent polymerase theta inhibitors33
Design, synthesis and validation of a new Crimped Head-Piece for DNA-Encoded libraries generation33
Exploring novel A2AAR antagonists: Design, synthesis, and evaluation of 2,6,9-trisubstituted purine derivatives as promising antifibrotic agents33
Research progress of STAT3-based dual inhibitors for cancer therapy32
Multiple approaches to repurposing drugs for neuroblastoma32
Antimycobacterial and anti-inflammatory activities of thiourea derivatives focusing on treatment approaches for severe pulmonary tuberculosis30
Targeting m6A binding protein YTHDFs for cancer therapy30
Janus dendritic ionizable lipids with fine designed headgroup and tails to improve mRNA delivery efficiency30
Selective targeting of human TET1 by cyclic peptide inhibitors: Insights from biochemical profiling30
Design, synthesis and evaluation the bioactivities of novel 1,3-dimethyl-6-amino-1H-indazole derivatives as anticancer agents29
Sustainable electrochemical C(sp3) − H oxygenation using water as the oxygen source29
0.72391414642334